Hemab Therapeutics Holdings Inc（COAG）價格預測

$34.400

-0.409 (-1.19%)收盤時

價格預測

1-Day Price Prediction

-1.67%

1-Week Prediction

-8.56%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

COAG 相似圖表分析預測

Alphio's COAG stock price prediction model matches the current Hemab Therapeutics Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $35.42 (-1.67%). The 1-week path is $32.94 (-8.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Hemab Therapeutics Holdings Inc 股票嗎？

Hemab Therapeutics (COAG) is a good buy right now due to its current price of $34.40, which is significantly below the analyst consensus target mean of $62.42, suggesting a potential upside of 105.68%. Additionally, the stock has shown a strong year-to-date change of +91.11%, indicating positive momentum. However, the main risk is the negative earnings per share (EPS) of -1.00 reported in Q2 2026, which reflects ongoing financial challenges.